a 2019

The benefits of apparent diffusion coefficient maps for high-grade glioma delineation

HENDRYCH, Michal, Hana VALEKOVÁ, Barbora MUSILOVÁ, Radim JANČÁLEK, Markéta HERMANOVÁ et. al.

Basic information

Original name

The benefits of apparent diffusion coefficient maps for high-grade glioma delineation

Authors

HENDRYCH, Michal (203 Czech Republic, guarantor, belonging to the institution), Hana VALEKOVÁ (703 Slovakia, belonging to the institution), Barbora MUSILOVÁ (203 Czech Republic, belonging to the institution), Radim JANČÁLEK (203 Czech Republic, belonging to the institution) and Markéta HERMANOVÁ (203 Czech Republic, belonging to the institution)

Edition

31st European Congress of Pathology, 2019

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30109 Pathology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.906

RIV identification code

RIV/00216224:14110/19:00112641

Organization unit

Faculty of Medicine

ISSN

UT WoS

000483546902068

Keywords in English

high-grade glioma delineation; apparent diffusion coefficient maps

Tags

Tags

International impact
Změněno: 14/4/2020 10:25, Mgr. Tereza Miškechová

Abstract

V originále

Apparent diffusion coefficient (ADC) maps provide voxel-based measures of the mean water diffusivity. As increased cellularity leads to restriction of water molecule diffusion, ADC maps can have better ability to describe and delineate gliomas rather than a structural MRI. The aim of our project was to determine whether the histological features and boundary of high-grade gliomas (HGG) might be predicted on the basis of ADC values.

Links

MUNI/A/1252/2017, interní kód MU
Name: Heterogenita významných histopatologických biomakerů na resekční hranici glioblastomu
Investor: Masaryk University, Category A
MUNI/A/1562/2018, interní kód MU
Name: HETEROGENITA VÝZNAMNÝCH HISTOPATOLOGICKÝCH BIOMAKERŮ NA RESEKČNÍ HRANICI GLIOBLASTOMŮ (detekce histopatologických markerů v tumorózní i peritumorózní tkáni a jejich klinická korelace)
Investor: Masaryk University, Category A